EFdA, a reverse transcriptase inhibitor, potently blocks HIV-1 ex vivo infection of langerhans cells within epithelium

Journal of Investigative Dermatology

Volumn 134, Issue 4, 2014, Pages 1158-1161

  Matsuzawa, Takamitsu ^a   Kawamura, Tatsuyoshi ^a   Ogawa, Youichi ^a   Maeda, Kenji ^b   Nakata, Hirotomo ^c   Moriishi, Kohji ^a   Koyanagi, Yoshio ^d   Gatanaga, Hiroyuki ^e   Shimada, Shinji ^a   Mitsuya, Hiroaki ^b,c  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4' ETHYNYL 2 FLUORO 2' DEOXYADENOSINE; MARAVIROC; MICROBICIDE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CD4 LYMPHOCYTE COUNT; COCULTURE; EPIDERMIS CELL; EPITHELIUM CELL; EX VIVO STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LANGERHANS CELL; LETTER; LYMPH NODE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RHESUS MONKEY; SEXUAL TRANSMISSION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; DIAZONIUM COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM; FARNESOL; HIV INFECTIONS; HIV-1; HUMANS; LANGERHANS CELLS; MICE; REVERSE TRANSCRIPTASE INHIBITORS; SKIN;

EID: 84897036718     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.467     Document Type: Letter

References (15)

1. Abdool Karim Q, Abdool Karim SS, Frohlich JA et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329:1168-74
2. Ganor Y, Zhou Z, Tudor D et al. (2010) Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Muco-sal Immunol 3:506-22
3. Hu J, Gardner MB, Miller CJ (2000) Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 74:6087-95
4. Kawamura T, Cohen SS, Borris DL et al. (2000) Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med 192: 1491-500
5. Lederman MM, Offord RE, Hartley O (2006) Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol 6:371-82
6. Michailidis E, Marchand B, Kodama EN et al. (2009) Mechanism of inhibition of HIV-1 reverse transcriptase by 4-Ethynyl-2-fluoro-2-deoxy- adenosine triphosphate, a translocation-defective reverse transcriptase inhibitor. J Biol Chem 284:35681-91
7. Nakata H, Amano M, Koh Y et al. (2007) Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4-ethynyl-2-fluoro-2-deoxyadenosine. Antimicrob Agents Chemother 51:2701-8
8. Nichols BE, Boucher CA, van de Vijver DA (2011) HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance. J Intern Med 270:532-49
9. Ogawa Y, Kawamura T, Kimura T et al. (2009) Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 113:5157-66
10. Ogawa Y, Kawamura T, Matsuzawa T et al. (2013) Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells. Cell Host Microbe 13:77-86
11. Ohrui H (2006) 2-deoxy-4-C-ethynyl-2-fluoro-adenosine, a nucleoside reverse transcriptase inhibitor, is highly potent against all human immunodeficiency viruses type 1 and has low toxicity. Chem Rec 6:133-43
12. Ohrui H, Kohgo S, Hayakawa H et al. (2007) 2-Deoxy-4-C-ethynyl-2- fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against wide spectrum of HIV-1 strains, favorable toxic profiles, and stability in plasma. Nucleosides, Nucleotides Nucleic Acids 26:1543-6
13. Rohan LC, Moncla BJ, Kunjara Na Ayudhya RP et al. (2010) In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS One 5:e9310
14. Zhou Z, Barry de Longchamps N, Schmitt A et al. (2011) HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells. PLoS Pathog 7:e1002100
15. Zhu T, Mo H, Wang N et al. (1993) Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261: 1179-81